Jyotika Singh
Jyotika Singh, senior principal consultant, HSJ Information
HSJ PartnersBehind every prescription is a person: reframing medicines optimisation for patient-centric impact in the NHS
Aspire Pharma Ltd initiated and funded this article but had no input into the content and was able to review it in advance of publication for factual accuracy and compliance checks only.
HSJ PartnersDigital transformation in the NHS: Navigating strategic shifts through system-wide coordination
The NHS 10-Year Health Plan, released in July 2025, establishes three fundamental shifts: analogue to digital, treatment to prevention, and hospital to community care.
HSJ PartnersLung cancer diagnosis in England: Can we do better?
Discussions and reflections from the HSJ Cancer Forum Panel discussion, 12 March 2025
HSJ PartnersUnlocking innovation in cancer care: A call to action for system-level change (AstraZeneca sponsored)
At a recent AstraZeneca UK sponsored HSJ roundtable event for NHS stakeholders, I had the privilege of hearing directly from clinicians, digital leads, and operational decision-makers across multiple cancer pathways.
HSJ InteractiveReimagining medicines optimisation: A call to action for reducing health inequalities
Aspire Pharma Ltd initiated and funded this article but had no input into the content and was able to review it in advance of publication for factual accuracy and compliance checks only.
HSJ PartnersIt’s time to optimise medicines optimisation
Working much more collaboratively, with a full range of partners, could improve the use of medicines in the NHS – so saving money and improving care, says Jyotika Singh, principal consultant, Wilmington Healthcare